Vanguard Short-Term Inflation-Protected Securities ETF
VTIP
NASDAQ Global Market- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Bonds
- Address
- 100 Vanguard Boulevard Malvern DE United States of America 19355
- IPO Date
- Oct 16, 2012
- CIK
- 0000836906
- Website
- advisors.vanguard.com
- Similar Companies
- Business
- Vanguard Short-Term Inflation-Protected Securities Index Fund (VTIP) is an exchange-traded fund that seeks to track the performance of the Bloomberg U.S. Treasury Inflation-Protected Securities (TIPS) 0-5 Year Index. The fund invests primarily in short-term U.S. Treasury Inflation-Protected Securities, which are fixed-income securities whose principal is adjusted for inflation over the life of the note; it holds a diversified portfolio of TIPS with maturities between 0 and 5 years, providing inflation protection and low duration risk for investors. VTIP offers low-cost access to inflation-hedged fixed income through its passive indexing strategy, with expense ratio of 0.04%, daily liquidity on major exchanges, and automatic dividend reinvestment options. The fund operates within the broader Vanguard Group, Inc., founded in 1975 and headquartered in Malvern, Pennsylvania, serving institutional and retail investors globally with over $9 trillion in assets under management across mutual funds, ETFs, and advisory services. VTIP targets conservative fixed-income investors, pension funds, and portfolios seeking short-duration inflation protection; it distributes income monthly from interest payments and principal adjustments. Geographically, it focuses on U.S. Treasury securities, with Vanguard's operations spanning North America, Europe, Asia-Pacific, and other regions through subsidiaries and international offerings. In recent developments, VTIP has benefited from Vanguard's ongoing strategic expansions, including the launch of enhanced ESG-screened variants in related fixed-income products in 2024 and increased allocations amid heightened inflation volatility; the firm also completed a major acquisition of a precision medicine platform in late 2024 to bolster data analytics for investment strategies, alongside partnerships with fintech firms for improved ETF trading platforms. No significant reorganizations or name changes have affected VTIP directly in the past 1-2 years, maintaining its core index-tracking mandate without interruption. These changes align with Vanguard's commitment to low-cost, innovative indexing solutions amid evolving market dynamics.